rs760856999
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_001144013.2(RGPD3):c.5051T>C(p.Met1684Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000205 in 1,611,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001144013.2 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 27 show subpopulations
GnomAD2 exomes AF: 0.0000284 AC: 7AN: 246284 AF XY: 0.0000449 show subpopulations
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1459692Hom.: 0 Cov.: 40 AF XY: 0.0000248 AC XY: 18AN XY: 726156 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152108Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 74284 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5051T>C (p.M1684T) alteration is located in exon 21 (coding exon 21) of the RGPD3 gene. This alteration results from a T to C substitution at nucleotide position 5051, causing the methionine (M) at amino acid position 1684 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at